Russia isn't the only country to use COVID-19 as a tool to fight perceived adversaries. US President Donald Trump routinely refers to SARS-CoV-2 as the “China virus”. He is seeking to amplify the American public's fear of China to wound his opponent in the current presidential campaign. In Latrobe, PA, on Sept 3, President Trump suggested that, “Joe Biden wants to surrender your jobs to China”. The message is clear—China is America's enemy, it is the cause of a pandemic that has destroyed the US economy, and the policies of the Democrat candidate will only strengthen America's chief international competitor. There is not one shred of evidence to support these claims. The twisting of language in public discussion of the pandemic is now standard fare. “Thanks to the efforts of Operation Warp Speed”, said President Trump in Wilmington, NC, on Sept 2, “we remain on track to deliver a vaccine very rapidly, in record time”. He has suggested a vaccine might be available by the end of October—an important claim given that the US election will take place on Nov 3. Yet there is no possibility that a COVID-19 vaccine will be ready for public use before the US election. Orwell's reflection that language is used “with intent to deceive” in “the sordid processes of international politics” could not be more apposite.
Saturday, September 12, 2020
Offline: The crisis of political language
George Orwell, in his 1945 essay Politics and the English Language, wrote that “to think clearly is a necessary first step towards political regeneration”. The Moscow press briefing held last week on the Russian COVID-19 vaccine quickly turned into a platform for national rivalry. The research, led by scientists at the N F Gamaleya National Research Centre for Epidemiology and Microbiology, found encouraging evidence of an immune response using their prime boost strategy of a two-component, human recombinant adenovirus vector-based vaccine. The study was small, non-randomised, uncontrolled, and did not include those most at risk of severe disease. The Russian team recognise these limitations and are proceeding with large randomised trials. The first results were released by Russian President Vladimir Putin on Aug 13. “I know that it works quite effectively”, he said, “forms strong immunity, and I repeat, it has passed all the needed checks”. At last week's event, more big claims were made. The “poorly researched approaches” by “western” nations were criticised, and one speaker challenged western governments to respond to these alleged concerns—“would you please show your citizens” evidence about the safety of western vaccine candidates given the “poorly developed platforms” you are using, he said. “It doesn't make any sense to use poorly researched approaches”, he argued. His view was that a human adenovirus vector was safer than a chimpanzee adenovirus vector (the basis for the Oxford COVID-19 vaccine, for example). A press conference to present the results of a scientific study became the venue for renewed Cold War conflict.
Labels:
The Lancet,
война,
грипп,
КНР,
США,
эпидемиология
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment